Your browser doesn't support javascript.
loading
Transient Changes in Serum CEA, CA19-9, CRP, YKL-40, and IL-6 during Adjuvant Chemotherapy and Survival of Patients with Colorectal Cancer.
Lehtomäki, Kaisa; Heervä, Eetu; Kellokumpu-Lehtinen, Pirkko-Liisa; Mustonen, Harri; Salminen, Tapio; Joensuu, Heikki; Hermunen, Kethe; Boisen, Mogens Karsbøl; Johansen, Julia Sidenius; Haglund, Caj; Osterlund, Pia.
Afiliação
  • Lehtomäki K; Faculty of Medicine and Health Technology, Tampere University, Arvo Ylpön katu 34, 33520 Tampere, Finland.
  • Heervä E; Department of Oncology: Tays Cancer Center, Tampere University Hospital, Teiskontie 35, 33520 Tampere, Finland.
  • Kellokumpu-Lehtinen PL; Department of Oncology, Turku University Hospital, Hämeentie 11, 20520 Turku, Finland.
  • Mustonen H; Department of Oncology, University of Turku, Kiinanmyllynkatu 10, 20520 Turku, Finland.
  • Salminen T; Faculty of Medicine and Health Technology, Tampere University, Arvo Ylpön katu 34, 33520 Tampere, Finland.
  • Joensuu H; Research, Development and Innovation Center, Tampere University Hospital, Teiskontie 35, 33520 Tampere, Finland.
  • Hermunen K; Department of Surgery, Helsinki University Hospital and University of Helsinki, Haartmaninkatu 4, 00290 Helsinki, Finland.
  • Boisen MK; Research Programs Unit, Translational Cancer Medicine Program, University of Helsinki, Haartmaninkatu 8, 00290 Helsinki, Finland.
  • Johansen JS; Department of Oncology: Tays Cancer Center, Tampere University Hospital, Teiskontie 35, 33520 Tampere, Finland.
  • Haglund C; Department of Oncology, Helsinki University Hospital and University of Helsinki, Haartmaninkatu 4, 00290 Helsinki, Finland.
  • Osterlund P; Department of Surgery, Helsinki University Hospital and University of Helsinki, Haartmaninkatu 4, 00290 Helsinki, Finland.
Int J Mol Sci ; 24(7)2023 Apr 04.
Article em En | MEDLINE | ID: mdl-37047727

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Antígeno CA-19-9 Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Finlândia

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Antígeno CA-19-9 Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Finlândia